Eli Lilly Upgraded, Best Buy Downgraded: Updated Rankings on Top Blue-Chip Stocks.

The financial landscape for large-cap equities underwent a significant reassessment on August 10, 2026, as market analysts and institutional investors recalibrated their positions following the latest wave of quarterly earnings and shifting macroeconomic data. Growth Investor editor Louis Navellier released a comprehensive update to his proprietary Stock Grader system, adjusting the ratings of 122 prominent blue-chip stocks. The revisions highlight a growing divergence between sectors, with energy and specific pharmaceutical giants gaining momentum while traditional retail and consumer staples face mounting pressure from shifting consumer behavior and institutional outflows.

The updates, which utilize a combination of quantitative measurements—tracking institutional buying pressure—and fundamental health assessments, serve as a barometer for the current state of the S&P 500 and broader global markets. Among the most notable shifts were the elevation of Eli Lilly and Company to a "Very Strong" rating and the simultaneous downgrade of retail stalwart Best Buy Co., Inc. to a "Neutral" status.

Sector Performance and the Energy Resurgence

A defining theme of the August 2026 ratings adjustment is the renewed strength of the energy sector. Despite global efforts toward energy transition, traditional oil and gas firms showed remarkable resilience in institutional demand. ConocoPhillips (COP), Devon Energy Corporation (DVN), Diamondback Energy, Inc. (FANG), and Occidental Petroleum Corporation (OXY) were all upgraded to the highest rating of "A."

Occidental Petroleum, in particular, stood out as one of the few companies to secure a perfect "A" grade in both quantitative and fundamental categories. This suggests that not only is the company exhibiting strong balance sheet health and earnings growth, but it is also being aggressively accumulated by large-scale institutional funds. The upgrade of Permian Resources Corporation (PR) and midstream players like MPLX LP and ONEOK, Inc. (OKE) further underscores a broader trend where investors are seeking refuge in cash-flow-heavy energy assets amid broader market volatility.

Analysts suggest that these upgrades are likely driven by a combination of disciplined capital expenditure among oil majors and a stabilized pricing environment for crude and natural gas. As geopolitical tensions continue to influence supply chains, these blue-chip energy firms have become focal points for "smart money" looking for defensive growth.

The Pharmaceutical Landscape: Eli Lilly and Merck Lead the Way

The healthcare and biotechnology sectors provided some of the most significant rating upgrades this week. Eli Lilly and Company (LLY) was elevated to a total grade of "A," reflecting "Very Strong" buying pressure. While its fundamental grade remained at a "C"—likely a reflection of high valuation multiples relative to historical averages—the quantitative "A" indicates that institutional appetite for the stock remains insatiable. This demand is largely attributed to the company’s continued dominance in the metabolic and endocrine therapeutic markets, specifically its advancements in GLP-1 treatments.

Similarly, Merck & Co., Inc. (MRK) saw an upgrade to a "Very Strong" rating. Like Eli Lilly, Merck’s fundamental grade sits at a "C," but its quantitative score of "A" suggests that the market is looking past short-term earnings fluctuations to focus on the company’s robust oncology pipeline and its long-term patent strategy. These moves indicate that in the current high-interest-rate environment, investors are prioritizing companies with high-barrier-to-entry products and significant market share.

Conversely, the sector was not without its laggards. Johnson & Johnson (JNJ) and Viatris, Inc. (VTRS) both saw their ratings slip from "Very Strong" to "Strong." While still considered viable holdings, the downgrades reflect a slight cooling of institutional enthusiasm as these firms navigate litigation complexities and the expiration of key product patents.

Consumer Retail and Staples: A Noticeable Cooling Trend

One of the most striking aspects of the August 10 report is the widespread downgrade of major consumer-facing brands. Best Buy Co., Inc. (BBY) was downgraded from "Strong" to "Neutral," finishing with a "C" grade across the board. This shift signals a potential slowdown in discretionary technology spending as households prioritize essential goods over electronics upgrades.

The cooling sentiment extended to the retail giant Walmart Inc. (WMT), which was also downgraded to a "Neutral" rating. Despite its reputation as a defensive play during economic downturns, Walmart’s quantitative grade dropped to a "B," while its fundamental grade remained at a "C." This suggests that even the most resilient retailers are not immune to the rising costs of logistics and a labor market that remains tight.

In the consumer staples category, even the "kings of the aisle" faced revisions. The Coca-Cola Company (KO) and its largest bottler, Coca-Cola Consolidated, Inc. (COKE), were both downgraded from "Very Strong" to "Strong." Similar trends were observed with Archer-Daniels-Midland Company (ADM) and The Kraft Heinz Company (KHC), the latter of which fell into "Weak" territory with a "D" grade. These adjustments reflect a broader market realization that the pricing power which fueled these stocks in 2024 and 2025 may be reaching its limit as consumers become increasingly price-sensitive.

Technology and Growth: Selective Resilience

The technology sector displayed a bifurcated performance in the latest ratings. Fortinet, Inc. (FTNT) and Twilio, Inc. (TWLO) were both upgraded to "Very Strong" status, driven by high quantitative scores. This indicates that cybersecurity and cloud-based communication services remain top priorities for institutional portfolios.

However, specialized hardware and semiconductor firms faced a more varied outlook. Super Micro Computer, Inc. (SMCI), a major player in the AI infrastructure space, was upgraded from "Weak" to "Neutral." While its fundamental grade remains a stellar "A," its quantitative grade of "D" suggests that institutional selling pressure or profit-taking has hindered its total score. This highlights the volatility inherent in the AI-driven tech boom, where even companies with exceptional earnings can see their stock prices suffer if institutional sentiment shifts.

On the downside, firms like Unity Software, Inc. (U) and Atlassian Corp (TEAM) remained in the "Neutral" or "Weak" categories, struggling to regain the high-growth momentum they enjoyed in previous cycles. The downgrade of Mastercard Incorporated (MA) to "Weak" further suggests that the financial technology and payment processing space is under scrutiny as transaction volumes and consumer credit health are monitored closely.

Methodology: Understanding Quantitative and Fundamental Grades

The ratings provided by the Stock Grader tool are calculated based on two primary pillars. The "Fundamental Grade" evaluates a company’s internal health, focusing on eight key metrics: sales growth, operating margin growth, earnings growth, earnings momentum, earnings surprises, analyst earnings revisions, cash flow, and return on equity.

The "Quantitative Grade" measures "buying pressure," which is a proxy for institutional interest. Large mutual funds, hedge funds, and pension funds move markets; when these entities buy in bulk, they create a "floor" for the stock price and drive upward momentum. A high quantitative grade (A or B) suggests that the "big money" is moving into the stock, regardless of current news cycles.

The "Total Grade" is a weighted average of these two components. In this latest update, many companies—such as Eli Lilly and Merck—attained "A" total grades despite "C" fundamentals because the institutional buying pressure was so overwhelmingly positive. This often happens when the market anticipates future growth that has not yet materialized in the quarterly balance sheets.

Market Implications and the Road Ahead

The widespread changes to these 122 blue-chip stocks suggest that the market is in a period of transition. The shift away from traditional consumer staples and toward energy and high-barrier healthcare indicates a "risk-aware" growth strategy among major investors.

For individual investors, these rating changes serve as a warning and an opportunity. The downgrade of staples like Johnson & Johnson and Walmart suggests that the "buy and hold forever" strategy may require more active management in 2026. Meanwhile, the surge in energy and specific tech sectors like cybersecurity offers a roadmap for where capital is likely to flow in the final quarters of the year.

As the 2026 fiscal year progresses, market participants will be watching for whether the "Neutral" ratings for retail giants like Best Buy and Walmart are temporary blips or the start of a longer-term secular decline in consumer discretionary strength. For now, the data suggests that institutional investors are placing their bets on "Old Economy" energy and "New Frontier" medicine, leaving traditional retail to navigate a more uncertain path.